CME Group (NASDAQ:CME) was downgraded by investment analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Tuesday.
A number of other brokerages have also recently issued reports on CME. Barclays lifted their target price on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. UBS restated a “buy” rating and issued a $135.00 target price (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Royal Bank of Canada lifted their target price on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $133.00 target price on shares of CME Group in a research report on Thursday, September 21st. Finally, Wells Fargo & Company raised their target price on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $141.75.
CME Group (NASDAQ CME) opened at $149.44 on Tuesday. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $50,921.51, a price-to-earnings ratio of 31.41, a P/E/G ratio of 3.09 and a beta of 0.73. CME Group has a 1-year low of $113.27 and a 1-year high of $155.29.
In related news, insider Hilda Harris Piell sold 1,350 shares of CME Group stock in a transaction on Thursday, October 5th. The stock was sold at an average price of $138.00, for a total transaction of $186,300.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total value of $342,075.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 38,953 shares of company stock valued at $5,642,851. 0.57% of the stock is currently owned by insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Fiduciary Trust Co. acquired a new stake in CME Group during the second quarter valued at $105,000. Quadrant Capital Group LLC boosted its position in CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares during the last quarter. Valeo Financial Advisors LLC acquired a new stake in CME Group during the third quarter valued at $124,000. San Francisco Sentry Investment Group CA acquired a new stake in CME Group during the second quarter valued at $129,000. Finally, People s United Financial Inc. boosted its position in CME Group by 11.5% during the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares during the last quarter. 82.70% of the stock is owned by hedge funds and other institutional investors.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.